Pathophysiology of Addiction

Psychiatry: Third Edition

Volumn 1, Issue , 2008, Pages 354-378

  Koob, George F ^a   Kandel, Denise ^b,c   Volkow, Nora D ^d   Kandel, Eric R ^b,e   Polan, H Jonathan ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e Kavli Institute for Brain Science   (United States)

Author keywords

Addiction; Amygdala; Dopamine; Epidemiology; Licit illicit drugs of abuse; Molecular mechanisms; Neuroadaptation; Neurobiology; Neuroimaging; Opioid peptides; Orbitofrontal cortex; Psychiatric comorbidity; Reward neurotransmitters; Stress neurotransmitters; Vulnerability

Indexed keywords

EID: 72049093567     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470515167.ch22     Document Type: Chapter

References (206)

1. Abreu-Villaca Y, Seidler FJ, Qiao D, et al. (2003) Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: Critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology 2, 1935-1949.
2. Adinoff B, Devous MD Sr., Best SM, et al. (2001) Limbic responsiveness to procaine in cocaine-addicted subjects. American Journal of Psychiatry 158, 390-398.
3. Adriani W, Spijker S, Deroche-Gamonet V, et al. (2003) Evidence for enhanced neurobehavioral vulnerability to nicotine during periadoles-cence in rats. Journal of Neuroscience 23, 4712-4716.
4. Ahmed SH, Kenny PJ, Koob GF, et al. (2002) Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nature Neuroscience 5, 625-626.
5. Ahmed SH and Koob GF (1998) Transition from moderate to excessive drug intake: Change in hedonic set point. Science 282, 298-300.
6. Ahmed SH, Walker JR, and Koob GF (2000) Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22, 413-421.
7. th edition. American Psychiatric Press, Washington, DC, USA.
8. th edition. American Psychiatric Press, Washington, DC, USA.
9. Anthony JC and Petronis KR (1995) Early-onset drug use and risk of later drug problems. Drug and Alcohol Dependence 40, 9-15.
10. Aston-Jones G, Delfs JM, Druhan J, et al. (1999) The bed nucleus of the stria terminalis: A target site for noradrenergic actions in opiate withdrawal. In Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychiatry and Drug Abuse. Annals of the New York Academy of Sciences, Vol. 877, McGinty JF (ed). New York Academy of Sciences, New York, NY, USA, pp 486-498.
11. Aston-Jones G and Harris GC (2004) Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47, 167-179.
12. Audrain-McGovern J, Rodriguez D, Wileyto EP, et al. (2006) Effect of team sport participation on genetic predisposition to adolescent smoking progression. Archives of General Psychiatry 63, 433-441.
13. Baumeister RF, Heatherton TF, and Tice DM (1994) Losing Control: How and Why People Fail at Self-Regulation. Academic Press, San Diego, CA, USA.
14. Bechara A and Damasio H (2002) Decision-making and addiction (part I): Impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsy-chologia 40, 1675-1689.
15. Belluzzi JD, Lee AG, Oliff HS, et al. (2004) Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) 174, 389-395.
16. Berrendero F, Kieffer BL, and Maldonado R (2002) Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. Journal of Neuroscience 22, 10935-10940.
17. Bierut LJ, Madden PA, Breslau N, et al. (2007) Novel genes identified in a high-density genome wide association study for nicotine dependence. Human Molecular Genetics 16, 24-35.
18. Breiter HC, Gollub RL, Weisskoff RM, et al. (1997) Acute effects of cocaine on human brain activity and emotion. Neuron 19, 591-611.
19. Breslau N and Klein DF (1999) Smoking and panic attacks: An epidemiological investigation. Archives of General Psychiatry 56, 1141-1146.
20. Breslau N, Novak SP, and Kessler RC (2004) Psychiatric disorders and stages of smoking. Biological Psychiatry 55, 69-76.
21. Breslau N, Peterson EL, Schultz LR, et al. (1998) Major depression and stages of smoking: A longitudinal investigation. Archives of General Psychiatry 55, 161-166.
22. Brody AL, Mandelkern MA, and London ED (2002) Brain metabolic changes during cigarette craving. Archives of General Psychiatry 59, 1162-1172.
23. Brook DW, Brook JS, Zhang C, et al. (2002) Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Archives of General Psychiatry 59, 1039-1044.
24. Budney AJ, Moore BA, Vandrey RG, et al. (2003) The time course and significance of cannabis withdrawal. Journal of Abnormal Psychology 112, 393-402.
25. Buka SL, Shenassa ED, and Niaura R (2003) Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: A 30-year prospective study. American Journal of Psychiatry 160 1978-1984.
26. Caine SB, Lintz R, and Koob GF (1993) Intravenous drug self-administration techniques in animals. In Behavioural Neuroscience: A Practical Approach, Vol. 2, Sahgal A (ed). IRL Press, Oxford, UK, pp 117-143.
27. Caspi A, Moffitt, TE, Cannon M, et al. (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry 57, 1117-1127.
28. Caspi A, Sugden K, Moffitt TE, et al. (2003) Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
29. Chen CC, Lu RB, Chen YC, et al. (1999) Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. American Journal of Human Genetics 65, 795-807.
30. Chen DC and Quock RM (1990) A study of central opioid receptor involvement in nitrous oxide analgesia in mice. Anesthesia Progress 37 181-185.
31. Childress AR, Mozley PD, McElgin W, et al. (1999) Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry 156, 11-18.
32. Chung T and Martin CS (2001) Classification and course of alcohol problems among adolescents in addictions treatment programs. Alcoholism: Clinical and Experimental Research 25, 1734-1742.
33. Collier HO (1980) Cellular site of opiate dependence. Nature 283, 625-629.
34. Collier HO and Francis DL (1975) Morphine abstinence is associated with increased brain cyclic AMP. Nature 255, 159-162.
35. Collins RJ, Weeks JR, Cooper MM, et al. (1984) Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology 82, 6-13.
36. Compton WM, Conway KP, Stinson FS, et al. (2005a) Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 66, 677-685.
37. Compton WM, Thomas YF, Conway KP, et al. (2005b) Developments in the epidemiology of drug use and drug use disorders. American Journal of Psychiatry 162, 1494-1502.
38. Compton WM, Thomas YF, Stinson FS, et al. (2007) Prevalence, correlates, disability and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 64, 566-576.
39. Conway KP, Compton W, Stinson FS, et al. (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67, 247-257.
40. Cottler LB (2007) Drug use disorders in the National Comorbidity Survey: Have we come a long way? Archives of General Psychiatry 64, 380-381.
41. Crabbe JC, Phillips TJ, Harris RA, et al. (2006) Alcohol-related genes: Contributions from studies with genetically engineered mice. Addiction Biology 11, 195-269.
42. Dahl RE and Spear LP (2004) Adolescent Brain Development: Vulnerability and Opportunities. New York Academy of Sciences, New York, NY, USA.
43. Dalack GW, Healy DJ, and Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. American Journal of Psychiatry 155, 1490-1501.
44. Day E, Bentham P, Callaghan R, et al. (2004) Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse. Cochrane Database of Systematic Reviews 1, CD004033.
45. Deroche-Gamonet V, Belin D, and Piazza PV (2004) Evidence for addictionlike behavior in the rat. Science 305, 1014-1017.
46. Di Chiara G (2002) Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behavioral Brain Research 137, 75-114.
47. Dick DM, Edenberg HJ, Xuei X, et al. (2004) Association of GABRG3 with alcohol dependence. Alcohol Clinical and Experimental Research 28, 4-9.
48. Drevets WC, Gautier C, Price JC, et al. (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biological Psychiatry 49, 81-96.
49. Edenberg HJ, Dick DM, Xuei X, et al. (2004) Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. American Journal of Human Genetics 74, 705-714.
50. Ernst M, Grant SJ, London ED, et al. (2003) Decision making in adolescents with behavior disorders and adults with substance abuse. American Journal of Psychiatry 160, 33-40.
51. Ernst M, Matochik JA, Heishman SJ, et al. (2001) Effect of nicotine on brain activation during performance of a working memory task. Proceedings of the National Academy of Sciences of the United States of America 98, 4728-4733.
52. Ezzati M and Lopez A (2003) Estimates of global mortality attributable to smoking in 2000. Lancet 362, 847-852.
53. Finney JW and Moos RH (1992) The long-term course of treated alcoholism: II. Predictors and correlates of 10-year functioning and mortality. Journal of Studies on Alcohol 53, 142-153.
54. Fowler T, Lifford K, Shelton K, et al. (2007) Exploring the relationship between genetic and environmental influences on initiation and progression of substance use. Addiction 102, 413-422.
55. Fowler JS, Logan J, Wang GJ, et al (2003) Monoamine oxidase and cigarette smoking. Neurotoxicology 24, 75-82.
56. Glantz MD and Hartel CR (1999) Drug Abuse: Origins and Interventions. American Psychological Association, Washington, DC, USA.
57. Glassman AH (1993) Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry 150, 546-553.
58. Glennon RA, Titeler M, and McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences 35, 2505-2511.
59. Goldstein RZ and Volkow ND (2002) Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. American Journal of Psychiatry 159, 1642-1652.
60. Grace AA (2000) The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95, S119-S128.
61. Grant BF, Compton WM, Crowley TJ, et al. (2007) Errors in assessing DSM-IV substance use disorders. Archives of General Psychiatry 64, 379-380.
62. Grant BF and Dawson DA (1998) Age of onset of drug use and its association with DSM-IV drug abuse and dependence: Results from the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse 10, 163-173.
63. Grant BF, Dawson DA, Stinson FS, et al. (2004a) The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug and Alcohol Dependence 74, 223-234.
64. Grant BF, Hasin DS, Chou SP, et al. (2004b) Nicotine dependence and psychiatric disorders in the United States. Archives of General Psychiatry 61, 1107-1115.
65. Grant S, London ED, Newlin DB, et al. (1996) Activation of memory circuits during cue-elicited cocaine craving. Proceedings of the National Academy of Sciences of the United States of America 93, 12040-12045.
66. Grant BF, Stinson FS, Dawson DA, et al. (2004c) Prevalence and cooccurrence of substance use disorders and independent mood and anxiety disorders. Archives of General Psychiatry 61, 807-816.
67. Grant BF, Stinson FS, Dawson DA, et al. (2004d) Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 61, 361-368.
68. Grant BF, Stinson FS, and Harford TC (2001) Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: A 12-year follow-up. Journal of Substance Abuse 13, 493-504.
69. Gresch PJ, Barrett RJ, Sanders-Bush E, et al. (2007) Serotonin-2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of lysergic acid diethylamide. Journal of Pharmacology and Experimental Therapeutics 320, 662-669.
70. Grucza RA, Abbacchi AM, Pryzbeck TR, et al. (2007) Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction 102, 623-629.
71. Gutstein HB and Akil H (2001) Opioid analgesics. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th edition, Hardman JG, Limbird LE, and Goodman-Gilman A (eds). McGraw-Hill, New York, NY, USA, pp 569-619.
72. Hasin DS, Goodwin RD, Stinson FS, et al. (2005) Epidemiology of major depressive disorder. Archives of General Psychiatry 62, 1097-1106.
73. Hawkins JD, Catalano RF, and Miller JY (1992) Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychological Bulletin 112, 64-105.
74. Heishman SJ, Singleton EG, and Liguori A (2001) Marijuana Craving Questionnaire: Development and initial validation of a self-report instrument. Addiction 96, 1023-1034.
75. Hernandez LM and Blazer DG (2006) Genes, Behavior, and the Social Environment: Moving Beyond the Nature/Nurture Debate. National Academies Press, Washington, DC, USA.
76. Hingson RW, Heeren T, and Winter MR (2006) Age at drinking onset and alcohol dependence. Archives of Pediatrics and Adolescent Medicine 160, 739-746.
77. Hoffman PL, Rabe CS, Moses F, et al. (1989) N-methyl-D-aspartate receptors and ethanol: Inhibition of calcium flux and cyclic GMP production. Journal of Neurochemistry 52, 1937-1940.
78. Hubbard RL, Craddock G, Flynn PM, et al. (1997) Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11, 261-278.
79. Hughes JR (2006) Should criteria for drug dependence differ across drugs? Addiction 101, 134-141.
80. Insel TR (1992) Toward a neuroanatomy of obsessive-compulsive disorder. Archives of General Psychiatry 49, 739-744.
81. Ito R, Dalley JW, Robbins TW, et al. (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. Journal of Neuroscience 22, 6247-6253.
82. Johnston LD, O'Malley PM, Bachman JG, et al. (2007) Monitoring the Future: National Results on Adolescent Drug Use-Overview of Key Findings 2006 (NIH publication No. 07-6202), National Institute on Drug Abuse, Bethesda, MD, USA.
83. Justinova Z, Tanda G, Redhi GH, et al. (2003) Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology 169, 135-140.
84. Kallen K (2001) The impact of maternal smoking during pregnancy on delivery outcome. European Journal of Public Health 11, 329-333.
85. Kandel DB (2002) Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Cambridge University Press, Cambridge, UK.
86. Kandel DB (2003) The natural history of smoking and nicotine dependence. In Proceedings of Symposium on Addictions: Impact on Canada. Royal Society of Canada, Ottawa, Ontario, Canada.
87. Kandel DB (2006) Developmental trajectories of drug use among African Americans. Paper presented at the meeting of National Institute on Drug Abuse Drug Use Trajectories Among African Americans, Bethesda, MD, USA.
88. Kandel DB and Chen K (2000) Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine and Tobacco Research 2, 263-274.
89. Kandel DB and Faust R (1975) Sequence and stages in patterns of adolescent drug use. Archives of General Psychiatry 32, 923-932.
90. Kandel DB, Wu P, and Davies M (1994) Maternal smoking during pregnancy and smoking by adolescent daughters. American Journal of Public Health 84, 1407-1413.
91. Karp I, O'Loughlin J, Hanley J, et al. (2006) Risk factors for tobacco dependence in adolescent smoking. Tobacco Control 15, 199-204.
92. Kathiramalainathan K, Kaplan HL, Romach MK, et al. (2000) Inhibition of cytochrome P450 2D6 modifies codeine abuse liability. Journal of Clinical Psychopharmacology 20, 435-444.
93. Kelley AE (2002) Nicotinic receptors: Addiction's smoking gun? Nature Medicine 8, 447-449.
94. Kenny PJ, Chen SA, Kitamura O, et al. (2006) Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. Journal of Neuroscience 26, 5894-5900.
95. Kessler RC (2004) The epidemiology of dual diagnosis. Biological Psychiatry 56, 730-737.
96. Kessler RC and Merikangas KR (2007) Drug use disorders in the National Comorbidity Survey: Have we come a long way?-Reply. Archives of General Psychiatry 64, 381-382.
97. Kessler RC, Berglund P, Demler O, et al. (2005a) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 593-602.
98. Kessler RC, Chiu WT, Demler O, et al. (2005b) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 617-627.
99. Khantzian EJ (1995) The 1994 distinguished lecturer in substance abuse. Journal of Substance Abuse Treatment 12, 157-165.
100. Khantzian EJ (1997) The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry 4, 231-244.
101. Khantzian EJ and Wilson A (1993) Substance abuse, repetition, and the nature of addictive suffering. In Hierarchical Concepts in Psychoanalysis: Theory, Research, and Clinical Practice, Wilson A and Gedo JE (eds). Guilford Press, New York, NY, USA, pp 263-283.
102. Kilts CD, Schweitzer JB, Quinn CK, et al. (2001) Neural activity related to drug craving in cocaine addiction. Archives of General Psychiatry 58, 334-341.
103. Kirk JM, Doty P, and De Wit H (1998) Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacology, Biochemistry and Behavior 59, 287-293.
104. Kitamura O, Wee S, Specio SE, et al. (2006) Escalation of methampheta-mine self-administration in rats: A dose-effect function. Psychopharmacology 186, 48-53.
105. Klungsøyr O, Nygård JF, Sørensen T, et al. (2006) Cigarette smoking and incidence of first depressive episode: An 11-year, population-based follow-up study. American Journal of Epidemiology 163, 421-432.
106. Kohut H (1971) The Analysis of the Self. The Psychoanalytic Study of the Child, Vol. 4. International Universities Press, New York, NY, USA.
107. Kolas T, Nakling J, and Salvesen KA (2000) Smoking during pregnancy increases the risk of preterm births among parous women. Acta Obstetri-cia et Gynecologica Scandinavica 79, 644-648.
108. Koob GF (1999) Stress, corticotropin-releasing factor, and drug addiction. In Neuropeptides: Structure and Function in Biology and Behavior. Annals of the New York Academy of Sciences, Vol. 897, Sandman C, Strand FL, Beckwith B, et al. (eds). New York Academy of Sciences, New York, NY,, USA, pp 27-45.
109. Koob GF (2003) Alcoholism: Allostasis and beyond. Alcoholism: Clinical and Experimental Research 27, 232-243.
110. Koob GF (2004) Allostatic view of motivation: Implications for psychopathology. In Motivational Factors in the Etiology of Drug Abuse. Nebraska Symposium on Motivation, Vol. 50, Bevins RA and Bardo MT (eds). University of Nebraska Press, Lincoln, NE, USA, pp 1-18.
111. Koob GF and Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242, 715-723.
112. Koob GF and Le Moal M (1997) Drug abuse: Hedonic homeostatic dys-regulation. Science 278, 52-58.
113. Koob GF and Le Moal M (2004) Drug addiction and allostasis. In Allosta-sis, Homeostasis, and the Costs of Physiological Adaptation, Schulkin J (ed). Cambridge University Press, New York, NY, USA, pp 150-163.
114. Koob GF and Le Moal M (2005) Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nature Neuroscience 8, 1442-1444.
115. Koob GF, Sanna PP, and Bloom FE (1998) Neuroscience of addiction. Neuron 21, 467-476.
116. Koob GF (2005) The neurocircuitry of addiction: Implications for treatment. Clinical Neuroscience Research 5, 89-101.
117. Kornetsky C and Bain G (1990) Brain-stimulation reward: A model for drug induced euphoria. In Testing and Evaluation of Drugs of Abuse. Modern Methods in Pharmacology, Vol. 6, Adler MW and Cowan A (eds). Wiley-Liss, New York, pp 211-231.
118. Kreek MJ and Koob GF (1998) Drug dependence: Stress and dysregulation of brain reward pathways. Drug and Alcohol Dependence 51, 23-47.
119. Kumari V and Postma P (2005) Nicotine use in schizophrenia: The self medication hypotheses. Neuroscience and Behavioral Reviews 29, 1021-1034.
120. Laakso A, Mohn AR, Gainetdinov RR, et al. (2002) Experimental genetic approaches to addiction. Neuron 36, 213-228.
121. Laruelle M, Abi-Dargham A, van Dyck CH, et al. (1995) SPECT imaging of striatal dopamine release after amphetamine challenge. Journal of Nuclear Medicine 36, 1182-1190.
122. Laviolette SR, Alexson TO, and van der Kooy D (2002) Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. Journal of Neuroscience 22, 8653-8660.
123. Law PY, Wong YH, and Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling, Annual Review of Pharmacology and Toxicology 40, 389-430.
124. Le Moal M (1995) Mesocorticolimbic dopaminergic neurons: Functional and regulatory roles. In Psychopharmacology: The Fourth Generation of Progress, Bloom FE and Kupfer DJ (eds). Raven Press, New York, NY, USA, pp 283-294.
125. Lee DE, Schiffer WK, and Dewey SL (2004) Gamma-vinyl GABA (viga-batrin) blocks the expression of toluene-induced conditioned place preference (CPP). Synapse 54, 183-185.
126. Lerman C and Berrettini W (2003) Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Americal Journal of Medical Genetics: Part B. Neuropsychiatric Genetics 118, 48-54.
127. Letchworth SR, Nader MA, Smith HR, et al. (2001) Progression of changes in dopamine transporter binding site density as a result of cocaine selfadministration in rhesus monkeys. Journal of Neuroscience 21 2799-2807.
128. Levin ED, Rezvani AH, Montoya D, et al. (2003) Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology 169, 141-149.
129. Linnet KM, Wisborg K, Obel C, et al. (2005) Smoking during pregnancy and the risk for hyperkinetic disorder in offspring. Pediatrics 116, 462-467.
130. Mansour A, Fox CA, Akil H, et al. (1995) Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends in Neurosciences 18, 22-29.
131. Martin-Solch C, Magyar S, Kunig G, et al. (2001) Changes in brain activation associated with reward processing in smokers and nonsmokers. A positron emission tomography study. Experimental Brain Research 139, 278-286.
132. McLellan AT, Lewis DC, O'Brien CP, et al. (2000) Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 284, 1689-1695.
133. McLellan AT and McKay J (1998) The treatment of addiction: What can research offer practice? In Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment, Lamb S, Greenlick MR, and McCarty D (eds). National Academy Press, Washington, DC, USA, pp 147-185.
134. McPherson CS and Lawrence AJ (2006) Exposure to amphetamine in rats during peridadolescence establishes behavioural and extrastriatal neural sensitization in adulthood. International Journal of Neuropsychopharmacology 9, 377-392.
135. Meyer RE (1996) The disease called addiction: Emerging evidence in a 200-year debate. Lancet 347, 162-166.
136. Morgan D, Grant KA, Gage HD, et al. (2002) Social dominance in monkeys: Dopamine D2 receptors and cocaine self-administration. Nature Neuroscience 5, 169-174.
137. National Institute on Alcohol Abuse and Alcoholism (2006) Alcohol Use and Alcohol Use Disorders in the United States: Main Findings from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) (NIH Publication No. 05-5737). U.S. Alcohol Epidemiologic Data Reference Manual, Vol. 8, No. 1.
138. Nelson CB, Rehm J, Ustun TB, et al. (1999) Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: Results from the WHO reliability and validity study. Addiction 94, 843-855.
139. Nestler EJ (2004) Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends in Pharmacological Sciences 25, 210-218.
140. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nature Neuroscience 8, 1445-1449.
141. Nestler EJ, Hope BT, and Widnell KL (1993) Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11, 995-1006.
142. Nestler EJ and Malenka RC (2004) The addicted brain. Scientific American 290, 78-85.
143. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience 2, 119-128.
144. Nestler EJ (1996) Under siege: The brain on opiates. Neuron 16, 897-900.
145. O'Brien CP and McLellan AT (1996) Myths about the treatment of addiction. Lancet 347, 237-240.
146. O'Dell LE and Koob GF (2007) "Nicotine deprivation effect" in rats with intermittent 23-hour access to intravenous nicotine self-administration. Pharmacology Biochemistry and Behavior 86, 346-353.
147. Ottman R (1996) Gene-environment interaction: Definitions and study designs. Preventive Medicine 25, 764-770.
148. Petronis KR and Anthony JC (2000) Perceived risk of cocaine use and experience with cocaine: Do they cluster within US neighborhoods and cities? Drug and Alcohol Dependence 57, 183-192.
149. Piazza PV and Le Moal M (1996) Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annual Review of Pharmacology and Toxicology 36, 359-378.
150. nd edition. Sinauer Associates, Inc., Sunderland, MA.
151. Rao Y, Hoffmann E, Zia M, et al. (2000) Duplications and defects in the CYP2A6 gene: Identification, genotyping, and in vivo effects on smoking. Molecular Pharmacology 58, 747-755.
152. Rasmussen K, Beitner-Johnson DB, Krystal JH, et al. (1990) Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological, and biochemical correlates. Journal of Neuroscience 10, 2308-2317.
153. Rezvani AH and Levin ED (2004) Adolescent and adult rats respond differently to nicotine and alcohol: Motor activity and body temperature. International Journal of Developmental Neuroscience 22, 349-354.
154. Ristuccia RC and Spear LP (2005) Sensitivity and tolerance to autonomic effects of ethanol in adolescent and adult rats during repeated vapor inhalation sessions. Alcoholism: Clinical and Experimental Research 29, 1809-1820.
155. Roberts AJ, Heyser CJ, Cole M, et al. (2000) Excessive ethanol drinking following a history of dependence: Animal model of allostasis. Neuropsychopharmacology 22, 581-594.
156. Roberts DCS, Koob GF, Klonoff P, et al. (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacology Biochemistry and Behavior 12, 781-787.
157. Robinson TE, Gorny G, Mitton E, et al. (2001) Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39, 257-266.
158. Rolls ET (2000) The orbitofrontal cortex and reward. Cerebral Cortex 10, 284-294.
159. Rosenkranz JA and Grace AA (2001) Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. Journal of Neuroscience 21, 4090-4103.
160. Royall DR, Lauterbach EC, Cummings JL, et al. (2002) Executive control function: A review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. Journal of Neuropsychiatry and Clinical Neurosciences 14, 377-405.
161. Samson HH (1986) Initiation of ethanol reinforcement using a sucrose-substitution procedure in food-and water-sated rats. Alcoholism: Clinical and Experimental Research 10, 436-442.
162. Schochet TL, Kelly AE, and Landry CF (2005) Differential expression of αrcmRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience 15, 285-297.
163. Schultz W, Tremblay L, and Hollerman JR (2000) Reward processing in primate orbitofrontal cortex and basal ganglia. Cerebral Cortex 10, 272-284.
164. See RE, Fuchs RA, Ledford CC, et al. (2003) The Amygdala in Brain Function: Basic and Clinical Approaches. Annals of the New York Academy of Sciences, Vol. 985. New York Academy of Sciences, New York, NY, USA, pp 294-307.
165. Self DW, McClenahan AW, Beitner-Johnson D, et al. (1995) Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21, 312-318.
166. Shah T, Sullivan K, and Carter J (2006) Sudden infant death syndrome and reported maternal smoking during pregnancy. American Journal of Public Health 96, 1757-1759.
167. Shaham Y, Erb S, and Stewart J (2000) Stress-induced relapse to heroin and cocaine seeking in rats: A review. Brain Research Reviews 33, 13-33.
168. Shaham Y, Shalev U, Lu L, et al. (2003) The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology 168, 3-20.
169. Sharma SK, Klee WA, and Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proceedings of the National Academy of Sciences USA 72, 3092-3096.
170. Shaw-Lutchman TZ, Barrot M, Wallace T, et al. (2002) Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. Journal of Neuroscience 22, 3663-3672.
171. Shiffman S, Waters AJ, and Hickcox M (2004) The nicotine dependence syndrome scale: A multi-dimensional measure of nicotine dependence. Nicotine and Tobacco Research 6, 327-348.
172. Shippenberg TS and Koob GF (2002) Recent advances in animal models of drug addiction and alcoholism. In Neuropsychopharmacology: The Fifth Generation of Progress, Davis KL, Charney D, Coyle JT, et al. (eds). Lippincott Williams and Wilkins, Philadelphia, PA, USA, pp 1381-1397.
173. Slawecki CJ and Roth J (2004) Comparison of the onset of hypoactivity and anxiety-like behavior during alcohol withdrawal in adolescent and adult rats. Alcoholism: Clinical and Experimental Research 28, 598-607.
174. Smith SM, Stinson FS, Dawson DA, et al. (2006) Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine 36, 987-998.
175. Sowell ER, Peterson BS, Thompson PM, et al. (2003) Mapping cortical change across the human life span. Nature Neuroscience 6, 309-315.
176. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neuroscience and Biobehavioral Reviews 24, 417-463.
177. SAMHSA: Substance Abuse and Mental Health Services Administration (2006) Results from the 2005 National Survey on Drug Use and Health: National Findings (Office of Applied Statistics, NSDUH Series H-30, DHHS Publication No. SMA 06-4194), Rockville, MD, USA.
178. Stein EA, Pankiewicz J, Harsch HH, et al. (1998) Nicotine-induced limbic cortical activation in the human brain: A functional MRI study. American Journal of Psychiatry 155, 1009-1015.
179. Tanda G, Pontieri FE, and Di Chiara G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276, 2048-2050.
180. Thanos PK, Volkow ND, Freimuth P, et al. (2001) Overexpression of dopamine D2 receptors reduces alcohol self-administration. Journal of Neurochemistry 78, 1094-1103.
181. Uhl GR (2004) Molecular genetics of substance abuse vulnerability: Remarkable recent convergence of genome scan results. In Current Status of Drug Dependence/Abuse Studies: Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity. Annals of the New York Academy of Science, Vol. 1025, Ali SF, Nabeshima T, and Yanagita T (eds). New York Academy of Science, New York, NY, USA, pp 1-13.
182. Uhl GR and Grow RW (2004) The burden of complex genetics in brain disorders. Archives of General Psychiatry 61, 223-229.
183. University of Michigan (2006) Teen drug use continues down in 2006, particularly among older teens; but use of prescription-type drugs remains high (December 21, 2006 press release). University of Michigan News and Information Services, Ann Arbor, MI, USA.
184. Vanderschuren LJ and Everitt BJ (2004) Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305, 1017-1019.
185. Volkow ND (2006) Altered pathways: Drug abuse and age of onset. Addiction Professional May/June, 26, 29.
186. Volkow ND and Fowler JS (2000) Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex 10, 318-325.
187. Volkow ND, Fowler JS, and Wang GJ (2002) Role of dopamine in drug reinforcement and addiction in humans: Results from imaging studies. Behavioural Pharmacology 13, 355-366.
188. Volkow ND, Fowler JS, Wang GJ, et al. (1993) Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14, 169-177.
189. Volkow ND, Fowler JS, Wolf AP, et al. (1991) Changes in brain glucose metabolism in cocaine dependence and withdrawal. American Journal of Psychiatry 148, 621-626.
190. Volkow ND, Hitzemann R, Wang GJ, et al. (1992) Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11, 184-190 [erratum: 12, 86].
191. Volkow ND, Wang GJ, Fowler JS, et al. (2000) Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions. Life Sciences 66, PL161-PL167.
192. Volkow ND, Wang GJ, Fowler JS, et al. (1999a) Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: Implications in addiction. American Journal of Psychiatry 156, 19-26.
193. Volkow ND, Wang GJ, Fowler JS, et al. (1997) Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386, 830-833.
194. Volkow ND, Wang GJ, Fowler JS, et al. (1999b) Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. Journal of Pharmacology and Experimental Therapeutics 291, 409-415.
195. Volkow ND, Wang G, Fowler JS, et al. (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal of Neuroscience 21, RC121.
196. Wagner FA and Anthony JC (2002) From first drug use to drug dependence: Developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 26, 479-488.
197. Wang GJ, Volkow ND, Fowler JS, et al. (1999) Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sciences 64, 775-784.
198. Watkins SS, Koob GF, and Markou A (2000) Neural mechanisms underlying nicotine addiction: Acute positive reinforcement and withdrawal. Nicotine and Tobacco Research 2, 19-37.
199. White DA and Holtzman SG (2005) Periadolescent morphine exposure alters subsequent behavioral sensitivity to morphine in adult rats. European Journal of Pharmacology 528, 119-123.
200. White NM (1996) Addictive drugs as reinforcers: Multiple partial actions on memory systems. Addiction 91, 921-949.
201. Wightman RM and Robinson DL (2002) Transient changes in mesolimbic dopamine and their association with 'reward'. Journal of Neurochemistry 82, 721-735.
202. Williams GM, O'Callaghan M, Najman JM, et al. (1998) Maternal cigarette smoking and child psychiatric morbidity: A longitudinal study. Pediatrics 102, e11.
203. Wood RW, Grubman J, and Weiss B (1977) Nitrous oxide self-administration by the squirrel monkey. Journal of Pharmacology and Experimental Therapeutics 202, 491-499.
204. th revision. Geneva, Switzerland.
205. World Health Organization (1999) World health report 1999. Making a difference. http://www.who.int/whr/1999
206. Yeomans J and Baptista M (1997) Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacology Biochemistry and Behavior 57, 915-921.